Instruction for authors

 | Post date: 2018/12/10 | 

 Instruction for Authors

 Papers are submitted to this journal should be observed the following criteria

  1. Papers should not have been submitted, under review or published in other journals and if previously presented in scientific meetings or conferences, this should be addressed in full detail.
  1. The corresponding author should send a commitment letter (click here) that includes the order and signature of authors before submission to commit that he/she will not add, delete, or rearrange the authors’ names after reviewing.
     Also, he/she should recommend 4-6 reviewers for accelerating the process of review.
  1. If a corresponding author changes the number or arrangement of authors, the editor-in-chief will reject the manuscript and all of their consequences are related to the corresponding author.
Submission of an article
To reduce delays, authors should assure that the level, length, and format of a manuscript submission conform.
Type of articles
Research articles, Review (Systematic, Meta-analysis), Case report, Short communication, Letter to the editor.
Author Guidelines
All manuscripts must be submitted through the journal’s online submission at We aim to provide all authors with an efficient, courteous, and constructive editorial process. Contributions should therefore be written clearly and simply so that they are accessible to readers in other disciplines and to readers for whom English is not their first language. Essential but specialized terms should be explained concisely but not didactically.
Manuscript format
The lines should be numbered continuously.
Title page information
Manuscript title
The title should be limited to 25 words or less and should not contain abbreviations. The title should be a brief phrase describing the contents of the paper.
Running title should be limited by 30-40 characters.
Author information
Complete names and affiliation of all authors accurately.
The responsibility of answering any future queries about material and methods will be handle by corresponding author, so he/she should be the professor of thesis. Write the information of  the corresponding author include: Affiliation, Telephone, Fax, and E-mail address
The Abstract should be informative and completely self-explanatory, briefly present the topic, state the scope of the experiments, indicate significant data, and point out major findings and conclusions. The abstract should summarize the manuscript content in 250 words or less. Standard nomenclature should be used and abbreviations should be avoided. The format should accommodate a description of the study background, methods, results, and conclusion.
Immediately after the abstract, provide list of keywords (3-5) according to MeSH. Be sparing with abbreviations: only abbreviations firmly established in the field may be eligible. These keywords will be used for indexing goals.
Define abbreviations that are not standard in this field in a footnote to be placed on the first page of the article. Such abbreviations that are unavoidable in the abstract must be defined at their first mention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article.
The introduction should set the tone of the paper by providing a clear statement of the study, the relevant literature on the study subject, and the proposed approach or solution. The introduction should be general enough to attract a reader’s attention from a broad range of scientific disciplines.
Materials and Methods
This section should provide a complete overview of the design of the study. Detailed descriptions of materials or participants, comparisons, interventions, and types of analysis should be mentioned. However, only new procedures should be described in detail; previously published procedures should be cited, and important modifications of published procedures should be mentioned briefly. Capitalize trade names and include the manufacturer’s name and address.
Ethical consideration
Human and animal rights
Research involving human subjects, human material, or human data, should include a statement that the studies performed in accordance with the Declaration of Helsinki and approved by an appropriate ethics committee. If a study has been granted an exemption from requiring ethics approval, this should also be detailed in the manuscript (including the name of the ethics committee that granted the exemption). Authors will be expected to have obtained ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool where a clear clinical advantage based on clinical need was not apparent before treatment.
Also, the welfare of animals used for research must be respected. When reporting experiments on animals, authors should indicate whether the international, national, and/or institutional guidelines for the care and use of animals have been followed, and that the studies have been approved by a research ethics committee at the institution or practice at which the studies were conducted (where such a committee exists)
Manuscripts were reporting from a clinical trial should be register the trials registries & bear a clinical trial registration number and name of the trial. Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT statement (
Manuscripts may be rejected if the Editor considers that the research has not been carried out within an appropriate ethical framework. In rare cases, Editors may contact the ethics committee for further information.
Informed consent
For all research involving human subjects, informed consent to participate in the study should be obtained from participants. For all manuscripts that include details, images, or videos relating to individual participants, written informed consent for the publication of these must be obtained from the participants. A statement to this effect should appear in the manuscript. Identifying details (names, dates of birth, identity numbers and other information) of the participants that were studied should not be published in written descriptions, photographs, and genetic profiles unless the information is essential for scientific purposes and the participant (or parent or guardian if the participant is incapable) gave written informed consent for publication. The final decision on whether consent to publish is required lies with the Editor.

The Results section should provide complete details of the experiment that are required to support the conclusion of the study. Results and Discussion should be in a separate section.
Tables should be typed on separate pages and numbered consecutively with Arabic numerals. Tables should be self-explanatory and include a brief descriptive title on top of them. Give each column a short or abbreviated heading. Explain in footnotes all nonstandard abbreviations that are used in each table. Footnotes should not include extensive experimental details. Be sure that each table is cited in the text respectively. If you use data from another published or unpublished source, obtain permission and acknowledge them fully.
Figures should be professionally drawn and photographed by 300 dpi resolution. If the photocopies are insufficiently clear for the referees to see the detail, glossy prints must also be submitted. Human subjects must not be identifiable in photographs, or their pictures must be accompanied by written permission to use the photograph. Figures should be numbered consecutively according to the order in which they have been first cited in the text.

Speculation and detailed interpretation of data should be put into the Discussion section.
Strengths and Limitations
Strengths and weaknesses of the study, both intrinsically and in relation to other studies, particularly any differences in results
Conflict of Interest
Authors are required to disclose all relationships or interests in relation to their work. All submitted manuscripts must include a ‘Conflict of Interest’ section at the end of the manuscript listing all financial and non-financial conflict of interests. Where authors have no conflict of interests, the statement should read “The authors declare that they have no conflict of interest.” A competing interest exists when the authors’ interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations.
 Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article. Financial competing interests include (but are not limited to):
  • Research grants from funding agencies (The research funder and the grant number are required)
  • Financial support for educational programs
  • Employment or consultation
  • Position on advisory board or board of directors or other type of management relationships
  • Financial relationships, for example Receiving reimbursements, fees, funding, or salary from an organization that may in any way gain or lose financially from the publication of the article, either now or in the future.
  • Intellectual property rights (e.g. patents, copyrights and royalties from such rights)
  • Holdings of spouse and/or children that may have financial interest in the work

In addition, non-financial interests that may be important to readers should be disclosed. These may include but are not limited to political, personal, religious, ideological, academic, and intellectual competing interests.

Editors may ask for further information relating to competing interests. Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists.


The author should identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the funding source(s) had no such involvement then this should be stated.

This section includes acknowledgment of people, grant details, funds, etc.
Note: If an author fails to submit his/her work as per the above instructions, they are pleased to maintain clear titles namely headings, subheadings.
Reference style and format
References should be consecutively numbered based on the Vancouver system. The journal name should be abbreviated according to PubMed. References should be listed as follows:
The family name and initials of author(s) (only 6 first authors are mentioned and the rest as et al), the article title, the journal-title, year of publication, the month of publication, volume (Issue): page number.
Garcia-Galiano D, Navarro VM, Gaytan F, Tena-Sempere M. Expanding roles of NUCB2/nesfatin-1 in neuroendocrine regulation. J Mol Endocrinol 2010 Nov; 45 (5): 281-90. doi: 10.1677/JME-10-0059.
The family name and initials of author(s) of the book (only 6 first authors are mentioned and the rest as et al), the book title, the family name, and initials of the translator(s) of the book, edition, the place of publication, publisher, the year of publication, page numbers (volume)
Coelli TJ, Rao D.S.P, O'Donnell CJ, Battese GE. An introduction to efficiency and productivity analysis. 2nd ed. Spring Science & Business 2005.

Process of Publication

View: 3728 Time(s)   |   Print: 439 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

© 2021 CC BY-NC 4.0 | Journal of Inflammatory Diseases

Designed & Developed by : Yektaweb